ABSTRACT OBJECTIVES This study describes the characteristics of a real-world Asian patient population treated with transcatheter aortic valve replacement (TAVR) and evaluates their clinical outcomes.
T ranscatheter aortic valve replacement (TAVR) has revolutionized the treatment of severe aortic stenosis in elderly patients and has been performed in >100,000 patients around the world (1, 2) . Numerous studies of the safety and efficacy of TAVR in Western countries have been published (3) (4) (5) (6) (7) (8) . Given the large elderly population in Asia, a substantial number of potential candidates for TAVR is expected. However, the proportion of Asian patients in previously published randomized or observational studies is very limited. Therefore, concerns persist regarding the safety and effectiveness of this novel technology applied to Asian patients due to their anatomic features, such as a small aortic root and vascular access sites which were previously reported to cause major complications and increase mortality. Therefore, there is a potential risk that the clinical outcomes could differ from those reported by previous studies in Western countries (9) (10) (11) .
The Asian TAVR registry was an international collaboration study that evaluated the safety and effectiveness of TAVR by using balloon-expandable or self-expanding prostheses for the treatment of severe aortic stenosis in Asian populations. 7.3%, respectively; p ¼ 0.001). Accordingly, the device success rate was significantly higher in the Sapien group (91.1% vs. 75.3%, respectively; p < 0.001).
METHODS
The rates of any stroke, life-threatening or major bleeding, major vascular complications, and acute kidney injury (stages 2-3) were 3.8%, 10.8%, 5.0%, and 3.3%, respectively. There were no differences between the devices in terms of major complications, except for a higher rate of vascular complications in the Sapien group (11.7% vs. 6.0%, respectively; p ¼ 0.008).
Rates of death from any cause at 30 days and at 1 and 2 years were 2.5%, 10.8%, and 16.7%, respectively (Online Figure 1 ). There were no differences in mortality between device subjects (HR: 1.33; 95% and HR of STS >8 vs. STS <4: 4.18; 95% CI: 2.52 to 6.93; p < 0.001) ( Figure 1B ). Furthermore, low body mass index and moderate or severe paravalvular leakage were significantly associated with increased mortality ( Figures 1C and 1D) .
On multivariate analysis, we found that the factors that had significant associations with mortality Table 3) . Given the optimized 3D assessment of the annulus Nevertheless, we acknowledge that a lower risk profile might have contributed to our favorable clinical outcomes. Finally, the lack of a core laboratory to centrally assess the echocardiographic findings could have led to an under-or overestimation of the paravalvular leakage grades. Also, there were no follow-up echocardiographic assessments in this study, which should be included in further studies.
CONCLUSIONS
Despite anatomic features of concern, the clinical outcomes of TAVR in Asian patients are comparable with those of previously published trials and observational studies from Western countries.
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